Argenx Stock Extends Rally In A Base As Earnings Loom
investors.com/research/argenx-stock-argx-autoimmune-disease-biotech/?src=A00220
is Wednesday's pick for Investor's Business Daily's IBD 50 Growth Stocks To Watch as the maker of autoimmune disease treatments recovers from a recent sell-off. Argenx stock is climbing off April lows in a base with earnings around the corner. The IBD 50 and IBD Leaderboard stock is…
This story appeared on investors.com, 2025-04-30 17:06:11.